Menorrhagia: Heavy Periods, Diagnosis, and Treatment

Menorrhagia has traditionally been defined as excessively heavy menstrual flow. Modern guidelines increasingly use the term "heavy menstrual bleeding" because the focus is no longer on the volume of blood in milliliters, but on the extent to which bleeding disrupts daily life, causes weakness, limits activity, and impairs sleep, work, sex, and emotional well-being. This approach is enshrined in the guidelines of the UK National Institute for Health and Care Excellence. [1]

The problem is very common, but its prevalence in studies varies widely, from 5% to 58%, because different studies used different definitions, questionnaires, and selection criteria. Furthermore, many women consider heavy periods "the norm" for years and do not seek help, so the true burden of the disease on the healthcare system and quality of life is often underestimated. [2]

It's important to understand that menorrhagia is not a standalone diagnosis in the narrow sense. It is a symptom that can be associated with uterine fibroids, polyps, adenomyosis, ovulation disorders, coagulation disorders, medications, endometrial pathology, and a number of other causes. This is why the same complaint in a 16-year-old girl and a 46-year-old woman may represent completely different clinical situations.

A separate issue is that heavy menstrual bleeding is one of the most common causes of iron deficiency and iron deficiency anemia in girls and women of reproductive age. In other words, treatment should be aimed not only at reducing blood loss but also at restoring iron stores. Otherwise, weakness, dizziness, hair loss, shortness of breath, and decreased cognitive performance may persist even after a partial improvement in the menstrual cycle itself. [4]

Another important point: heavy periods do not equal "any heavy period." If bleeding increases rapidly, if a pad or tampon is completely soaked in less than an hour several times in a row, if there are large clots, severe weakness, fainting, severe pain, or a suspicion of pregnancy, it may no longer be a routine visit but a condition requiring urgent evaluation.

Table 1. Signs that heavy periods become a clinical problem

Sign	What does this mean in practice?
Very frequent change of hygiene products	High probability of significant blood loss
Night leaks	Bleeding is already affecting daily life
Large clots	Increased blood loss is possible
Weakness, shortness of breath, tachycardia	Need an anemia assessment
Pain, pressure in the lower abdomen	It is necessary to look for myoma, adenomyosis, endometriosis
Intermenstrual bleeding	Polyps and endometrial pathology should be excluded.
Debut with menarche	We need to think about coagulopathy.
Bleeding due to a delay in menstruation	First, pregnancy and its complications are ruled out.

The table is compiled according to modern diagnostic algorithms and criteria for heavy menstrual bleeding. [6]

Causes and risk factors

The modern system of causes is based on the International Federation of Gynecology and Obstetrics classification, known as PALM-COEIN. Its essence is that all causes are divided into structural and non-structural. Structural causes include polyps, adenomyosis, leiomyomas (myomas), and malignant or pre-cancerous endometrial processes. Non-structural causes include coagulopathies, ovulatory dysfunction, endometrial causes, iatrogenic factors, and causes that are currently difficult to accurately classify.

In adolescents and young women, the search for a cause differs from that in adults. Structural causes are less common, with anovulatory cycles and coagulation disorders becoming more prominent. If heavy bleeding begins almost immediately after the first period, is accompanied by frequent bruising, bleeding gums, prolonged nosebleeds, or a family history of bleeding, von Willebrand disease and other coagulopathies should be seriously considered. [8]

In reproductive age, common causes include fibroids, especially submucosal fibroids, endometrial polyps, adenomyosis, and ovulatory disorders. In some patients, heavy menstrual bleeding is associated with more than one factor. For example, a woman may simultaneously have a small fibroid, obesity, irregular ovulation, and iron deficiency, making the complaint particularly severe.

During perimenopause, the risk shifts toward endometrial hyperplasia and malignant processes, although benign causes remain common. Therefore, persistent intermenstrual bleeding, irregular, prolonged bleeding, especially in the setting of obesity, polycystic ovary syndrome, diabetes, tamoxifen treatment, or initial treatment failure, require a more careful assessment of the endometrium. [10]

Iatrogenic causes should be taken into account separately. These include anticoagulants, certain hormonal medications, copper-containing intrauterine devices, and situations following uterine surgery. A time-related connection between the start of medication and increased bleeding should always be documented at the first appointment, as sometimes adjusting the treatment regimen can improve the situation more quickly than complex diagnostic imaging.

Table 2. Main causes of heavy periods

Group of reasons	Examples	Clinical clues
Polyps	Endometrial polyp	Intermenstrual discharge, local intracavitary pathology
Adenomyosis	Invasion of endometrial tissue into the myometrium	Pain, enlarged and painful uterus
Leiomyomas	Submucous and other fibroids	Pressure, enlarged uterus, heavy periods
Endometrial hyperplasia and cancer	Precancer, carcinoma	Age-related risk factors, irregular and atypical bleeding
Coagulopathies	Von Willebrand disease and others	Onset with menarche, bleeding in other situations
Ovulatory dysfunction	Anovulatory cycles, polycystic ovary syndrome	Irregular cycles, long delays
Endometrial causes	Local disorders of endometrial hemostasis	Heavy periods without an obvious structural cause
Iatrogenic causes	Anticoagulants, some contraceptives, intrauterine devices	Relationship with initiation of therapy or device

The table is based on the current classification of causes of abnormal uterine bleeding.

Symptoms, consequences and situations requiring urgent help

The main symptom of menorrhagia is not simply the subjective sensation of "heavy periods." Clinically significant situations include bleeding that interferes with normal activity, requires frequent changes in hygiene products, causes nighttime leaks, is accompanied by the passage of large clots, lasts an unusually long time, or recurs too frequently. The severity of the symptoms can vary from woman to woman, even with similar amounts of blood loss, so the impact of the symptom on quality of life remains the primary focus. [13]

The second layer of symptoms is associated not with the bleeding itself, but with its consequences. The most typical are weakness, fatigue, decreased exercise tolerance, dizziness, palpitations, decreased concentration, headaches, and sometimes hair loss. These complaints are often underestimated, although they are often the first manifestation of iron deficiency, even before severe anemia develops. [14]

If fibroids or adenomyosis are the cause, the clinical picture often expands. These include nagging pain, a feeling of pressure in the lower abdomen, painful periods, a feeling of heaviness in the pelvis, and sometimes frequent urination or constipation due to the uterine mass pressing on adjacent organs. With adenomyosis, pain and bleeding often go hand in hand. [15]

Urgent assessment is necessary if signs of hemodynamic instability or severe blood loss are present. These include fainting, pre-syncope, severe weakness, shortness of breath, rapid pulse, rapidly soaking pads several times in a row, worsening symptoms over hours, and severe pain associated with possible pregnancy. In such cases, the physician's task is not only to find the cause but also to stabilize the condition. [16]

A special rule applies to the postmenopausal period. After established menopause, any bleeding is considered abnormal and requires a separate diagnostic approach, as the range of possible causes changes in this age group, and the importance of excluding endometrial neoplasia increases. Therefore, postmenopausal bleeding cannot be described in the same terms as menorrhagia in women with normal menstrual cycles. [17]

Table 3. When urgent rather than planned care is needed

Situation	Why is this dangerous?
Completely soaking the pad in less than 1 hour several times in a row	Risk of significant acute blood loss
Fainting, severe weakness, cold sweat	Hemodynamic instability is possible
Severe pain and delayed periods	It is necessary to exclude ectopic pregnancy and other pregnancy complications.
Bleeding after menopause	A separate oncological exclusion is required.
Bleeding with fever	An infectious or other complicated cause is possible.
Large clots and rapid onset of symptoms	An urgent assessment of the severity of the condition is needed.

The table summarizes the signs that severe bleeding should not lead to a routine appointment alone. [18]

Diagnostics

Diagnosis begins not with hardware methods, but with a properly collected medical history. It is necessary to clarify the duration of the problem, the regularity of the cycle, the presence of intermenstrual bleeding, pain, pelvic pressure, nighttime leaks, clots, the relationship with medications, the desire to preserve fertility, and the impact of bleeding on quality of life. Current recommendations emphasize that it is the medical history that helps determine which initial examination method will be most useful. [19]

Basic laboratory tests include a complete blood count, and for all patients with potential for fertility, a mandatory pregnancy test. This is a simple but critical step, as bleeding during early pregnancy can be mistaken for "very heavy periods." Additional hormonal testing is not performed on everyone, but is prescribed only when clinically indicated. [20]

Coagulation disorders should be specifically investigated. According to guidelines, testing for coagulopathy should be considered in women who have experienced heavy periods from the onset of menstruation and who have a personal or family history of bleeding. This is especially important in adolescents, as coagulopathy remains a leading cause of heavy bleeding after anovulation. [21]

The choice between hysteroscopy and ultrasound depends on the clinical presentation. If a submucosal myoma, polyp, or endometrial pathology is suspected, especially with persistent intermenstrual bleeding, outpatient hysteroscopy is considered a more informative initial approach. However, if large myomas, an enlarged uterus, a pelvic mass, or if examination is difficult are suspected, a pelvic ultrasound is often the first choice. [22]

If adenomyosis is suspected, transvaginal ultrasound is usually preferred. Magnetic resonance imaging is not used as a first-line procedure for heavy menstrual bleeding, but is reserved for specific clinical situations when ultrasound imaging is inconclusive or a more precise disease map is required. Similarly, saline sonography is not considered a first-line procedure. [23]

Not everyone needs an endometrial biopsy. According to current algorithms, it is performed in the context of hysteroscopy in women with a high risk of endometrial pathology, such as persistent intermenstrual or irregular bleeding, obesity and rare heavy bleeding, polycystic ovary syndrome, while taking tamoxifen, or after treatment failure. Blind biopsy without hysteroscopic guidance is not routinely recommended. However, a number of practical guidelines for outpatient care indicate that biopsy should be considered especially vigorously in women 45 years of age and older with abnormal bleeding. [24]

Table 4. What each study provides

Study	When is it especially useful?	What helps to identify
Complete blood count	To all patients	Anemia and indirect severity of blood loss
Pregnancy test	To all with preserved fertility	Pregnancy and its complications
Screening for coagulopathy	Onset at menarche, familial bleeding	Von Willebrand disease and other hemostatic disorders
Transvaginal ultrasound	Suspected fibroids, adenomyosis, pelvic mass	Structural pathology of the uterus
Outpatient hysteroscopy	Suspected polyps, submucous fibroids, endometrial pathology	Intracavitary pathology, the possibility of targeted biopsy
Endometrial biopsy	Risk factors for hyperplasia and cancer, treatment failure	Hyperplasia and malignant process
Magnetic resonance imaging	Controversial cases, clarification of anatomy	Additional detail, but not the first routine step

The table corresponds to the modern step-by-step approach to examination. [25]

Differential diagnosis

The first thing to rule out in a woman of reproductive age with bleeding is pregnancy and its complications. Even if the patient is certain it's "just her period," early pregnancy, threatened miscarriage, miscarriage, or ectopic pregnancy can clinically masquerade as unusually heavy menstrual bleeding. Therefore, a pregnancy test is considered a basic, rather than supplemental, assessment method. [26]

The second important step is to distinguish menorrhagia from other forms of abnormal uterine bleeding. If bleeding occurs between periods, after sexual intercourse, irregularly, after long delays, or after menopause, this is a different diagnostic framework. In such cases, cervical pathology, endometrial pathology, ovulatory disorders, and systemic causes become increasingly important. [27]

The third area of differential diagnosis involves local gynecological pathology. Submucous fibroids often cause a combination of heavy menstrual flow and pressure symptoms, polyps often suggest intermenstrual bleeding, and adenomyosis is often accompanied by painful periods and an enlarged, painful uterus. None of these signs are completely specific, but together they provide a good guide to the choice of the first imaging method. [28]

Systemic causes should not be overlooked. Thyroid pathology, coagulopathy, severe ovulatory disorders, sometimes severe somatic diseases, and drug effects are also among the possible explanations. However, current guidelines emphasize that hormonal analyses and thyroid function tests should not be performed without a clinical basis, lest the examination turn into an expensive and unhelpful "screening for everything." [29]

Finally, with persistent atypical bleeding, it's important to keep an eye out for endometrial hyperplasia and cancer. The absolute risk of serious pathology in premenopausal women with heavy periods without additional symptoms is not as high as sometimes thought, but it increases significantly in the presence of risk factors and with atypical bleeding patterns. Therefore, the goal of differential diagnosis is not to "do everything for everyone," but to identify those who require a more in-depth evaluation. [30]

Table 5. How menorrhagia differs from other conditions

State	What helps to distinguish
Heavy menstrual bleeding	There is bleeding during the days of menstruation, the cycle can be maintained
Bleeding during pregnancy	There is a delay, a positive test, pain, an atypical course
Intermenstrual bleeding	Blood appears outside of the usual menstrual period
Postmenopausal bleeding	Any blood after established menopause
Submucosal fibroid	Heavy periods plus signs of intracavitary deformation
Adenomyosis	Pain, heavy periods, enlarged and painful uterus
Coagulopathy	Onset with menarche, bleeding in other situations
Drug-induced bleeding	Relationship with initiation of medication or device placement

The table reflects practical guidelines and does not replace a full diagnosis. [31]

Treatment

Treatment should answer four questions at once: how heavy is the bleeding, whether there is anemia or iron deficiency, what is the cause, and whether the woman wants to preserve fertility. Current guidelines emphasize that treatment success is measured not only by reducing blood loss but also by improving quality of life. Therefore, the same therapy may be a good choice for one patient and a bad one for another. [32]

If no significant structural pathology is detected, if the fibroids are smaller than 3 cm and do not distort the uterine cavity, or if adenomyosis is suspected, a levonorgestrel-containing intrauterine system (IUS) is often considered the first treatment option. NICE guidelines list this option as the priority. Clinical trial data show that a 52 mg levonorgestrel IUS can reduce blood loss by more than 90% over 6 months in most patients. [33]

If the intrauterine system is unsuitable or the patient refuses it, other medication options are considered. Among non-hormonal agents, tranexamic acid is the most important, reducing menstrual blood loss by approximately 40% to 50% per cycle and is particularly useful when therapy without ovulation suppression is needed. Non-steroidal anti-inflammatory drugs also reduce bleeding and are particularly useful for pain, but are generally less effective than tranexamic acid and the levonorgestrel intrauterine system. [34]

Hormonal medications include combined hormonal contraception and cyclic oral progestogens. These can reduce bleeding, help with dysmenorrhea, and improve cycle control, but the choice depends on contraindications, age, concomitant risk factors for thrombosis, migraine, smoking, and reproductive plans. In routine practice, therapy is selected individually, rather than on a "one-size-fits-all" basis. [35]

If heavy periods are caused by fibroids 3 cm or larger, the approach changes. Not only medications but also uterine artery embolization, myomectomy, endometrial ablation in appropriate cases, and hysterectomy as a definitive solution should be considered. In certain clinical situations, gonadotropin-releasing hormone antagonists are available for women with fibroids, and in some premenopausal patients with moderate to severe symptoms, ulipristal acetate may be considered, but only with strict safety precautions and liver function monitoring. [36]

In acute severe bleeding, the approach is different. Priority is given to stabilizing the patient's condition, assessing hemodynamics, replenishing circulating blood volume if necessary, administering antifibrinolytic therapy, high-dose hormonal regimens when appropriate, and promptly considering procedural intervention if medications are ineffective or there is a structural cause. Iron deficiency must also be treated, as controlling bleeding without correcting iron stores does not fully resolve the problem. [37]

Table 6. Comparison of the main treatment methods

Method	Who is it most suitable for?	Key Benefits	Restrictions
Levonorgestrel-containing intrauterine system	There is no significant cavity deformation, long-term therapy is required	The most significant reduction in blood loss, long-lasting effect	Not suitable for everyone due to anatomy and personal preferences
Tranexamic acid	Non-hormonal therapy is needed	Taken during bleeding days, does not suppress ovulation	Doesn't address the structural cause
Nonsteroidal anti-inflammatory drugs	There is pain and moderate increase in bleeding	Helps with dysmenorrhea	Usually weaker in hemostatic effect
Combined hormonal contraception	Cycle control and contraception are needed.	Regulates the cycle and reduces bleeding	There are contraindications
Oral progestogens	Estrogens are not allowed or another hormonal option is needed	May reduce bleeding	Efficiency varies
Hysteroscopic removal of a polyp or submucous myoma	Intracavitary cause confirmed	Eliminates a specific cause	Invasive method
Uterine artery embolization	Symptomatic fibroids when preserving the uterus is desired	Organ-preserving option	Not for all reproductive plans
Myomectomy	Fibroids and the desire to preserve fertility	Removal of fibroids with preservation of the uterus	Surgical risk, possible relapse
Endometrial ablation	No plans for pregnancy	Can dramatically reduce bleeding	Not suitable if you want to get pregnant
Hysterectomy	Severe symptoms, failure of other treatments	The final decision	Loss of fertility and the risk of surgery

The table summarizes the current hierarchy of treatment options adopted in current guidelines.[38]

Prevention and prognosis

Not all causes of menorrhagia can be prevented, as fibroids, adenomyosis, and some ovulation disorders are not solely influenced by behavior or diet. However, preventing serious consequences is much more possible than is commonly thought. To achieve this, it's important not to normalize heavy periods, but to promptly assess whether your cycle has changed, whether clots have appeared, whether pain has increased, whether weakness has developed, or whether exercise tolerance has decreased. [39]

Practically meaningful prevention begins with monitoring the cycle. Keeping a menstrual diary, noting the frequency of changing sanitary products, the presence of leaks, clots, and pain, helps not only the doctor but also the patient understand whether the situation is changing. Recent reviews emphasize that self-assessment of symptoms and their impact on life is often no less important than trying to roughly "count the milliliters."

A separate area of prevention is iron deficiency management. If periods are heavy and prolonged, one should not rely solely on gynecological treatment for improvement. According to the World Health Organization and recent reviews, iron deficiency remains a major problem in menstruating girls and women, and correcting iron stores improves not only laboratory parameters but also well-being. [41]

The prognosis is favorable in most cases if the cause is identified and treatment is appropriate. In some patients, good control can be achieved with medication, in others with minimally invasive procedures, and in others with surgical treatment. An unfavorable prognosis is often associated not with menorrhagia itself as a symptom, but with delayed diagnosis of anemia, intracavitary pathology, or endometrial disease. [42]

The best results are achieved when treatment is tailored not to a template, but to the individual woman's specific needs: age, reproductive plans, presence of pain, size and location of fibroids, risk of endometrial pathology, hormone tolerance, severity of iron deficiency, and preference for preserving the uterus. This personalized approach is considered the standard for quality care today. [43]

FAQ

Is heavy menstrual bleeding normal if it's always been this way?
No. Even if bleeding has been heavy since adolescence, that doesn't make it normal. This scenario is especially important for ruling out coagulopathies and chronic iron deficiency. [44]

Is a pregnancy test necessary if bleeding resembles a period?
Yes, for all women with preserved fertility, this is a basic diagnostic step. Pregnancy and its complications can disguise themselves as abnormal bleeding. [45]

Is an ultrasound always necessary?
It's not always the first step. If polyps, submucous fibroids, or endometrial pathology are suspected based on complaints, an outpatient hysteroscopy may be a more informative initial approach. [46]

When is an endometrial biopsy truly necessary?
It is especially important in cases of risk factors for endometrial pathology, including persistent intermenstrual or irregular bleeding, obesity, polycystic ovary syndrome, tamoxifen use, and treatment failure. Many practice guidelines specifically emphasize caution in women 45 years of age and older with abnormal bleeding. [47]

What is considered the best medical treatment?
If there is no significant deformation of the uterine cavity and no contraindications, the levonorgestrel-containing intrauterine system (IUS) is considered one of the most effective options. Studies have shown a significant reduction in blood loss. [48]

Is tranexamic acid a hormone?
No, it's a non-hormonal antifibrinolytic agent. It's usually taken during periods of bleeding and can reduce menstrual blood loss by approximately 40% to 50%. [49]

Do regular painkillers help?
Nonsteroidal anti-inflammatory drugs (NSAIDs) can reduce both pain and bleeding, but are generally inferior in hemostatic effectiveness to tranexamic acid and the levonorgestrel intrauterine system (IUS). [50]

Is it possible to cure the problem permanently?
Sometimes yes, if the specific cause, such as a polyp or submucous fibroid, can be removed, or if a hysterectomy is performed. But for many patients, the goal is not a "one-time cure," but long-term symptom control while preserving the uterus and fertility. [51]

Should iron deficiency be treated separately if bleeding is already decreasing?
Yes. Modern reviews emphasize that heavy menstrual periods often lead to iron deficiency, and without correction, weakness and other symptoms may persist even after blood loss has decreased. [52]

When is surgery necessary?
Surgical treatment is considered if medications are ineffective, if the cause is structural and well-localized, if symptoms are severe, or if the patient prefers a more definitive solution. The choice depends on the cause, age, and reproductive plans. [53]